Clinical Trial Update: Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on the safety and PK/PD of SHR3824 in adults with type 2 diabetes and renal insufficiency; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency
• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Renal Insufficiency,Type 2 Diabetes | Phase 1 | Status: UNKNOWN